Polyphenol rich botanicals used as food supplements interfere with EphA2-ephrinA1 system

Iftiin Hassan Mohamed1, Carmine Giorgio, Renato Bruni

  • 1Dipartimento di Scienze Farmacologiche, Biologiche e Chimiche Applicate, Università di Parma, Viale G.P. Usberti 27a, 43124 Parma, Italy.

Insights

Edible plant extracts can modulate the EphA2-ephrinA1 system, a key player in cancer development. Nine polyphenol-rich extracts inhibited cancer cell signaling without toxicity, suggesting dietary compounds may influence cancer progression.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Pharmacology

Background:

  • Eph tyrosine kinase receptors and ephrin ligands are crucial in human cancers, promoting aggressive tumor phenotypes.
  • Dysregulated Eph-ephrin signaling contributes to tumorigenesis and cancer progression.
  • Green tea extracts (GTE) have demonstrated inhibitory effects on Eph-kinase phosphorylation.

Purpose of the Study:

  • To screen edible and medicinal plant extracts for their ability to modulate the EphA2-ephrinA1 system.
  • To investigate the potential of plant-derived compounds in targeting cancer-related signaling pathways.

Main Methods:

  • A high-throughput ELISA-based binding assay was used to screen 133 plant extracts.
  • Functional studies on PC3 prostate adenocarcinoma cells assessed the inhibition of ephrinA1-Fc-induced EphA2-phosphorylation.
  • Assays were performed at non-cytotoxic concentrations to evaluate specificity.

Main Results:

  • Nine plant extracts, rich in polyphenols, demonstrated reversible, dose-dependent inhibition of EphA2-ephrinA1 binding (IC₅₀ 0.83–24 μg/ml).
  • Active extracts antagonized EphA2-phosphorylation in PC3 cells at non-cytotoxic concentrations (IC₅₀ 0.31–11.3 μg/ml).
  • The observed inhibition was specific, as these extracts did not interfere with EGF-induced EGFR activation.

Conclusions:

  • Edible plant extracts containing polyphenols can specifically inhibit the EphA2-ephrinA1 signaling pathway.
  • These findings suggest a potential link between diet, plant secondary metabolites, and cancer modulation via the Eph-ephrin system.
  • Plant-derived compounds represent a promising avenue for developing novel strategies targeting cancer signaling.

Related Concept Videos

Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...